Characteristics | N(%) |
---|---|
Median Age, year (range) | 53.5(30–81) |
≤ 50 | 18(39.1%) |
> 50 | 28(60.9%) |
Gender | |
Male | 25(54.3%) |
Female | 21(45.7%) |
T classification | |
1 | 1(2.2%) |
2 | 8(17.4%) |
3 | 26(56.5%) |
4 | 11(23.9%) |
N classification | |
0 | 22(47.8%) |
1 | 16(34.8%) |
2 | 8(17.4%) |
3 | 0(0.0%) |
M classification | |
x | 0(0.0%) |
0 | 42(91.3%) |
1 | 4(8.7%) |
Clinical stage | |
I | 5(10.9%) |
II | 15(32.6%) |
III | 22(47.8%) |
IV | 4(8.7%) |
Preoperative radiotherapy | |
25 Gy | 17(100.0%) |
50 Gy | 29(0.0%) |
Preoperative chemotherapy | |
Yes | 36(78.3%) |
Induction | 8(17.4%) |
Concurrent | 24(52.2%) |
Induction + Concurrent | 4(8.7%) |
No | 10(21.7%) |
Chemotherapy cycles | |
≤ 3 | 30(65.2%) |
> 3 | 16(34.8%) |